Topic: Health
Researchers at UCLA Health have developed a new approach to treating depression using transcranial magnetic stimulation (TMS). The accelerated method involves five sessions per day for five consecutive days, which showed similar results to the standard six-week treatment. This could be a game-changer for people struggling with depression.
Depression is a serious condition that affects many people worldwide. While standard antidepressant medications can help, they don't always bring enough relief. In such cases, transcranial magnetic stimulation (TMS) has become an important alternative. TMS uses magnetic pulses to activate targeted areas of the brain linked to mood.
Traditionally, TMS requires patients to visit a clinic every weekday for six to eight weeks. This schedule can be difficult for people balancing work, family, transportation, or health challenges. However, researchers at UCLA Health have developed an accelerated approach that could change this.
The accelerated method involves five sessions per day for five consecutive days, known as the 5x5 treatment. The goal was to see whether compressing the schedule would still provide meaningful symptom relief. The findings, published in the Journal of Affective Disorders, included 175 patients with treatment-resistant depression.
Both groups experienced significant reductions in depression symptoms, and there was no statistically significant difference in overall outcomes between the two treatment schedules. This suggests that the accelerated method could be a viable option for people struggling with depression.
One of the most noteworthy observations involved patients in the accelerated group who did not show much progress immediately after finishing their five-day course. When researchers checked back two to four weeks later, those individuals demonstrated substantial improvement, with depression scores dropping by an average of 36%. This suggests that evaluating accelerated TMS right at the end of the five-day period may not tell the full story.
What Comes Next for TMS Research While the accelerated method produced promising results, the standard six-week course still showed stronger performance on certain longer-term measures. The researchers also emphasized that this was not a randomized clinical trial, meaning participants were not randomly assigned to each treatment group. Larger, carefully controlled studies will be needed to confirm the findings.
Beyond depression, UCLA scientists are studying TMS for other conditions, including obsessive-compulsive disorder and chronic pain. As research expands, TMS may play a growing role in the next generation of brain-based treatments for mental health.
Why It Matters
This new approach could be a game-changer for people struggling with depression in India. With the accelerated method, patients may not have to wait six weeks for treatment, which could make a huge difference in their daily lives.
Key Facts
- Researchers at UCLA Health developed an accelerated TMS treatment that involves five sessions per day for five consecutive days.
- The accelerated method showed similar results to the standard six-week treatment for patients with treatment-resistant depression.
- Patients who received the accelerated treatment experienced significant reductions in depression symptoms, and there was no statistically significant difference in overall outcomes between the two treatment schedules.
- Some patients may not show much progress immediately after finishing their five-day course, but they can still experience substantial improvement two to four weeks later.
- Larger, carefully controlled studies will be needed to confirm the findings of this study.
Key Terms
- Transcranial magnetic stimulation (TMS)
- A noninvasive therapy that uses magnetic pulses to activate targeted areas of the brain linked to mood
Implications
This new approach could be a game-changer for people struggling with depression in India. With the accelerated method, patients may not have to wait six weeks for treatment, which could make a huge difference in their daily lives.
Source: https://www.sciencedaily.com/releases/2026/02/260224023103.htm
Journal Reference:
- Michael R. Apostol, Thomas E. Valles, Juliana Corlier, Michael K. Leuchter, Alexander S. Young, Hewa Artin, Ralph J. Koek, Evan H. Einstein, Scott A. Wilke, Hanadi A. Oughli, Thomas Strouse, Aaron Slan, Margaret G. Distler, Dustin Z. DeYoung, Nathaniel Ginder, David E. Krantz, Andrew F. Leuchter. Efficacy of 5 × 5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression. Journal of Affective Disorders, 2026; 403: 121345 DOI: 10.1016/j.jad.2026.121345
Leave a Comment